Where can I buy Sanofi stock?
Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sanofi's stock price today? One share of SNY stock can currently be purchased for approximately $47.99. How much money does Sanofi make?
How much money does Sanofi make a year?
Sanofi has a market capitalization of $121.01 billion and generates $41.17 billion in revenue each year. The company earns $14.07 billion in net income (profit) each year or $2.93 on an earnings per share basis.
How much is a sny stock worth?
One share of SNY stock can currently be purchased for approximately $47.99. How much money does Sanofi make? Sanofi has a market capitalization of $121.01 billion and generates $41.17 billion in revenue each year.
Why is Sanofi investing $180 million in French startup Owkin?
Drugmaker Sanofi is investing $180 million in French startup Owkin, whose predictive algorithms aim to improve the research and development of new cures against cancer, the Paris-based group said on Thursday.
See more
Is Sanofi stock a good buy?
Valuation metrics show that Sanofi may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of SNY, demonstrate its potential to outperform the market. It currently has a Growth Score of D.
Is Sanofi on NYSE?
Sanofi shares have been listed on Euronext Paris since May 25, 1999. They were also listed on the New York Stock Exchange in the form of ADSs (American Depositary Shares) between July 1, 2002 and December 31, 2018. Since January 2, 2019, Sanofi ADSs are listed on the Nasdaq Global Select Market (Nasdaq).
Who is Sanofi owned by?
Sanofi Pasteur was the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines....Sanofi Pasteur.TypeDivisionNumber of employees15,000ParentSanofi4 more rows
How much is Sanofi company worth?
120 billion U.S. dollarsSanofi S.A. had a total assets value of over 120 billion U.S. dollars in 2021, which is the highest asset value the company has had over the past decade.
Does Sanofi pay a dividend?
Sanofi pays a dividend 1 times a year. The payment month is May. The dividend calendar shows you for more than 1,000 dividend stocks in which month which company distributes its dividends. Plan your passive income for the whole year.
Why is Sanofi stock up?
Sanofi Ramps Up Cost-Cutting to Fund Drug Pipeline as Earnings Beat Estimates. The Stock Is Rising. Sanofi stock climbed on Friday, after the French drug company posted better-than-expected fourth-quarter earnings and said it was targeting further cost cuts.
Is Sanofi a Fortune 500 company?
Sanofi is #289 on the 2020 Fortune Global 500. The Fortune Global 500 is an annual ranking of the top corporations worldwide as measured by revenue.
Is Sanofi a good company?
Glassdoor rating: 3.6 According to Glassdoor ratings, Sanofi scored highest in the categories of compensation and benefits and work/life balance, and 70% of employees would recommend the company as a place to work to a friend.
Is Sanofi a big company?
Sanofi $30.6 French multinational pharmaceutical giant, Sanofi is the eighth largest pharmaceutical company in the world by revenue. Sanofi provides healthcare solutions to 170 countries worldwide and has three core focuses: speciality care, vaccines, and general medicines.
What is Sanofi best known for?
Sanofi-Synthélabo is known for creating meningitis treatment, Menactra, diabetes treatment Lantus, colorectal cancer drug Eloxatin, and lung, prostate and breast cancer drug Taxorete.
How big is Sanofi?
SanofiFormerlySanofi-Synthélabo (1999–2004) Sanofi-Aventis (2004–2011)Total assets€120.24 billion (2021)Total equity€68.68 billion (2021)Number of employees95,442 (2021)SubsidiariesSanofi Pasteur Genzyme Shantha Biotechnics Chattem Ablynx Bioverativ14 more rows
What drugs does Sanofi make?
Medications AvailableAdacel® Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Absorbed. ... Admelog® (insulin lispro injection) 100 Units/mL. ... Apidra® (insulin glulisine injection) 100 Units/mL. ... Imogam® Rabies-HT Rabies Immune Globulin (Human) USP, Heat Treated.More items...
Should I buy or sell Sanofi stock right now?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last twelve months. There are currently 7 buy ratings for th...
What is Sanofi's stock price forecast for 2022?
7 Wall Street research analysts have issued 12 month target prices for Sanofi's shares. Their forecasts range from $85.00 to $127.00. On average, t...
How has Sanofi's stock performed in 2022?
Sanofi's stock was trading at $50.10 on January 1st, 2022. Since then, SNY shares have increased by 1.6% and is now trading at $50.91. View the be...
When is Sanofi's next earnings date?
Sanofi is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Sanofi .
How were Sanofi's earnings last quarter?
Sanofi (NASDAQ:SNY) released its earnings results on Thursday, April, 28th. The company reported $1.09 EPS for the quarter, beating the consensus e...
How often does Sanofi pay dividends? What is the dividend yield for Sanofi?
Sanofi announced an annual dividend on Friday, April 22nd. Shareholders of record on Thursday, May 5th will be paid a dividend of $1.7968 per share...
Is Sanofi a good dividend stock?
Sanofi(NASDAQ:SNY) pays an annual dividend of $1.26 per share and currently has a dividend yield of 2.42%. The dividend payout ratio of Sanofi is 4...
Who are Sanofi's key executives?
Sanofi's management team includes the following people: Mr. Paul Hudson , CEO & Director (Age 55, Pay $5.94M) Mr. Jean-Baptiste Chasseloup de Ch...
What is Paul Hudson's approval rating as Sanofi's CEO?
277 employees have rated Sanofi CEO Paul Hudson on Glassdoor.com . Paul Hudson has an approval rating of 94% among Sanofi's employees. This puts P...
Why Moderna Stock Is Falling Today
Sanofi-GSK Prepare Regulatory Filings For COVID-19 Vaccine After Booster Data
What happened Shares of Moderna (NASDAQ: MRNA) were down by 5.3% as of 1:25 p.m. ET Wednesday. The company announced a long-term collaboration with Thermo Fisher Scientific to manufacture messenger RNA (mRNA) vaccines.
How much did Sanofi make in the quarter?
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NYSE: GSK) are seeking regulatory approval for their COVID-19 vaccine to be used as a booster, as well as a standalone two-dose shot.
Does Sanofi have a dividend?
Sanofi (NASDAQ:SNY) released its quarterly earnings data on Wednesday, April, 28th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.83 by $0.14. The business earned $8.59 billion during the quarter, compared to analyst estimates of $8.48 billion.
What is Sanofi valuation?
Sanofi does not yet have a strong track record of dividend growth. The dividend payout ratio of Sanofi is 40.90%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Sanofi will have a dividend payout ratio of 32.01% next year.
When did Sanofi change its name?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales.
Is Sanofi a French company?
It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication.
Where can I buy Sanofi stock?
Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales. Originally, the company was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, ...
Is Sanofi listed on NASDAQ?
Sanofi is listed on NASDAQ under SNY. You can buy Sanofi stock through any online brokerage account such as E*TRADE, Charles Schwab, or Merrill Edge. Premium subscribers can easily link their Seeking Alpha portfolios to their brokerage account.
Recently Viewed Tickers
Sanofi is listed on NASDAQ under SNY. You can buy Sanofi stock through any online brokerage account such as E*TRADE, Charles Schwab, or Merrill Edge. Premium subscribers can easily link their Seeking Alpha portfolios to their brokerage account. (Your credentials will never be made accessible to Seeking Alpha.)
Sanofi
Visit a quote page and your recently viewed tickers will be displayed here.
